Latest Action: 03/11/2008 - Referred to the Subcommittee on Health. Bill TextExpressing the need for enhanced public awareness of Hidradenitis Suppurativa, and for the support of the designation of a National Hidradenitis Suppurativa Awareness Month. 3/11/2008--Introduced. Expresses support for the designation of a National Hidradenitis Suppurativa Awareness Month. Requests the President to call on the medical community and other interested groups to engage in educational activities and promote the need for further Hidradenitis Suppurativa research.
Also tagged in: Access to health care, Arthritis, Autoimmune diseases, Clinical trials, Coinsurance, Communication in medicine, Communication in science, Communications, Conferences, Congressional reporting requirements, Directories, Drugs, Education, Epidemiology, Finance, Genetic research, Governmental investigations, Health education, Health information systems, Health insurance, Health policy, Higher education, Medical care, Medical education, Medical records, Medical research, Medical tests, Medicine, Pharmaceutical research, Prescription pricing, Quality of life, Science policy
Latest Action: 05/23/2007 - Sponsor introductory remarks on measure. (CR S6554-6555) Bill TextA bill to strengthen the Nation's research efforts to identify the causes and cure of psoriasis and psoriatic arthritis, expand psoriasis and psoriatic arthritis data collection, study access to and quality of care for people with psoriasis and psoriatic arthritis, and for other purposes. 5/23/2007--Introduced. Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to expand and intensify research and related NIH activities with respect to psoriasis and psoriatic arthritis. Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to conduct or support research to expand understanding of the causes of, and to find a cure for, psoriasis and psoriatic arthritis. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to establish [...] show full description
Also tagged in: Abortion, Actions and defenses, Administrative fees, Administrative procedure, Agriculture, Agriculture in foreign trade, Animals, Antibiotics, Biomedical engineering, Budgets, Business, Canada, Cancer, Chemotherapy, Child health, Children, Clinical trials, Communicable diseases, Communication in medicine, Communications, Conflict of interests, Congress, Congressional investigations, Congressional oversight, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Counterfeiting, Criminal justice, Data banks, Defective products, Department of Health and Human Services, Drug abuse, Drug adulteration, Drug approvals, Drug industry, Drug interactions, Drug law enforcement, Drug therapy, Drug utilization, Drugs, Education, Electronic data interchange, Elementary and secondary education, Environmental protection, Executive departments, Eye diseases, Families, Federal advisory bodies, Federal aid to education, Federal aid to research, Federal reserve system, Fines (Penalties), Food, Food additives, Food and Drug Administration (FDA), Food industry, Food preservation, Food safety, Food supply, Foodborne diseases, Foundations, Fraud, Generic drugs, Genetic counseling, Genetic engineering, Genetics, Government information, Government paperwork, Government publicity, Hazardous substances, Health information systems, Health surveys, Health warnings, Higher education, Imaging systems in medicine, Import restrictions, Intellectual property, Internet, Labeling, Law, Marijuana, Meat, Medical care, Medical education, Medical instruments and apparatus, Medical laboratories, Medical records, Medical statistics, Medical supplies, Medicinal plants, Medicine, Orphan drugs, Packaging, Parent and child, Parental consent, Patent infringement, Pediatrics, Pesticides, Pets, Pharmaceutical research, Pharmacists, Physical examinations, Politics and government, Preschool education, Prescription pricing, Prices, Produce trade, Product development, Product safety, Protection of animals, Public meetings, Research and development, Research grants, Restrictive trade practices, Risk, Salmonella, Scholarships, Science policy, Seafood, Shellfish, Skin cancer, Small business, Social services, Strategic planning, Student loan funds, Technology, Telecommunication, Trade, Turtles, User charges, Web sites
Latest Action: 05/10/2007 - Received in the House. Bill TextAn act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. 5/9/2007--Passed Senate amended. (There are 2 other summaries) Food and Drug Administration Revitalization Act - Title I: Prescription Drug User Fees - (Sec. 101) - Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to set forth as a purpose that authorized prescription drug fees be dedicated toward expediting the drug development process, the process for the review of human drug applications, and postmarket drug safety. Sets forth reporting requirements, including requiring the Secretary of Human Services (the Secretary) to present to Congress recommendations developed for achieving certain goals for the review process of human drug applications and for reauthorization of user [...] show full description
Also tagged in: Barber and beauty shops, Business, Congressional reporting requirements, Consumers, Equipment and supplies, Eye diseases, Governmental investigations, Hazardous substances, Medical care, Medicine, Product safety, Skin cancer, Ultraviolet radiation, Warning labels
Latest Action: 02/16/2007 - Sponsor introductory remarks on measure. (CR S2178) Bill TextA bill to require the Food and Drug Administration to conduct consumer testing to determine the appropriateness of the current labeling requirements for indoor tanning devices and determine whether such requirements provide sufficient information to consumers regarding the risks that the use of such devices pose for the development of irreversible damage to the skin, including skin cancer, and for other purposes. 2/16/2007--Introduced. Tanning Accountability and Notification Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to determine whether: (1) the labeling requirements for indoor tanning devices provide sufficient information to consumers regarding the risks that the use of such devices pose for the development of irreversible damage to the eyes and skin, including skin cancer; (2) adding the warning suggested by the American Academy of Dermatology or any other additional warning to the current warning [...] show full description
Also tagged in: Access to health care, Arthritis, Autoimmune diseases, Clinical trials, Coinsurance, Communication in medicine, Communication in science, Communications, Conferences, Congressional reporting requirements, Directories, Drugs, Education, Epidemiology, Finance, Genetic research, Governmental investigations, Health education, Health information systems, Health insurance, Health policy, Higher education, Medical care, Medical education, Medical records, Medical research, Medical tests, Medicine, Pharmaceutical research, Prescription pricing, Quality of life, Science policy
Latest Action: 03/05/2007 - Sponsor introductory remarks on measure. (CR E457) Bill TextTo strengthen the Nation's research efforts to identify the causes and cure of psoriasis and psoriatic arthritis, expand psoriasis and psoriatic arthritis data collection, study access to and quality of care for people with psoriasis and psoriatic arthritis, and for other purposes. 2/16/2007--Introduced. Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to expand and intensify research and related NIH activities with respect to psoriasis and psoriatic arthritis. Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to conduct or support research to expand understanding of the causes of, and to find a cure for, psoriasis and psoriatic arthritis. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to establish a national [...] show full description
Also tagged in: Barber and beauty shops, Business, Congressional reporting requirements, Consumers, Equipment and supplies, Eye diseases, Governmental investigations, Hazardous substances, Medical care, Medicine, Product safety, Skin cancer, Ultraviolet radiation, Warning labels
Latest Action: 02/09/2007 - Referred to the Subcommittee on Health. Bill TextTo require the Food and Drug Administration to conduct consumer testing to determine the appropriateness of the current labeling requirements for indoor tanning devices and determine whether such requirements provide sufficient information to consumers regarding the risks that the use of such devices pose for the development of irreversible damage to the skin, including skin cancer, and for other purposes. 2/8/2007--Introduced. Tanning Accountability and Notification Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to determine whether: (1) the labeling requirements for indoor tanning devices provide sufficient information to consumers regarding the risks that the use of such devices pose for the development of irreversible damage to the eyes and skin, including skin cancer; (2) adding the warning suggested by the American Academy of Dermatology or any other additional warning to the current warning label [...] show full description
Also tagged in: Administrative procedure, Aged, Cardiovascular diseases, Case management, Case mix (Medical care), Communicable diseases, Congressional reporting requirements, Department of Health and Human Services, Digestive diseases, Executive departments, Finance, Government information, Government paperwork, Government publicity, Governmental investigations, Health policy, Hospital administration, Hospital care, Hospital rates, Hospitals, Kidney diseases, Labor, Law, Long-term care, Medicaid, Medical care, Medical records, Medicare, Medicine, Metabolism, Nervous system diseases, Performance measurement, Physicians, Quality of care, Respiratory diseases, Rural affairs, Rural health, Urban affairs, Wages, Welfare
Latest Action: 01/18/2007 - Sponsor introductory remarks on measure. (CR S765) Bill TextA bill to amend title XVIII of the Social Security Act to ensure and foster continued patient quality of care by establishing facility and patient criteria for long-term care hospitals and related improvements under the Medicare program. 1/18/2007--Introduced. Medicare Long-Term Care Hospital Improvement Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to prescribe requirements for a long-term care hospital (LTCH) and patient criteria for prospective payment to an LTCH.Directs the Secretary of Health and Human Services to: (1) determine a list of medical conditions associated with a high severity of illness of patients who are appropriate for treatment in long-term care hospitals, as indicated by the presence of clinical comorbidities in accordance with a methodology specified by the Secretary; and (2) study and report to Congress on appropriate quality measures for Medicare beneficiaries receiving care in LTCHs. Directs the Secretary to [...] show full description
Also tagged in: Administrative procedure, Aged, Cardiovascular diseases, Case management, Case mix (Medical care), Communicable diseases, Congressional reporting requirements, Department of Health and Human Services, Digestive diseases, Executive departments, Finance, Government information, Government paperwork, Government publicity, Governmental investigations, Health insurance, Health policy, Hospital administration, Hospital care, Hospital rates, Hospitals, Kidney diseases, Labor, Law, Long-term care, Medicaid, Medical care, Medical records, Medicare, Medicine, Metabolism, Nervous system diseases, Performance measurement, Physicians, Quality of care, Respiratory diseases, Wages, Welfare
Latest Action: 01/24/2007 - Referred to the Subcommittee on Health. Bill TextTo amend title XVIII of the Social Security Act to ensure and foster continued patient quality of care by establishing facility and patient criteria for long-term care hospitals and related improvements under the Medicare Program. 1/18/2007--Introduced. Medicare Long-Term Care Hospital Improvement Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to prescribe requirements for a long-term care hospital (LTCH) and patient criteria for prospective payment to an LTCH. Directs the Secretary of Health and Human Services to: (1) determine the LTCH diagnosis related groups (LTCH-DRGs) associated with a high severity of illness for specified medical conditions; and (2) study and report to Congress on appropriate quality measures for Medicare patients receiving care in LTCHs.Directs the Secretary to choose three quality measures from the study for LTCHs to report.Amends the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act [...] show full description
Latest Action: 01/04/2007 - Referred to the House Committee on Oversight and Government Reform. Bill TextExpressing the sense of the House of Representatives that there should be established a National Inflammatory Skin Disease Awareness Month. 1/4/2007--Introduced. Calls for the establishment of a National Inflammatory Skin Disease Awareness Month.
|
Bill Categories in Federal Government
|